Jaroslav Rosenberger, Tatiana Baltesová, Mária Majerníková, Monika Michrinová
Kidney transplantation is the method of choice in treatment of end-stage renal disease due to longer survival, lower morbidity and costs and improved quality of life. 22-year old female developed rapid proggressive glomerulonephritis due to ANCA positive necrotising vasculitis in her 11 years and shortly became anuric and dialysis dependant. She started long-term hemodialysis program in 1998; kidney transplantation in 1999 was unsuccessful due to renal vein thrombosis. She had several relapses of vasculitis during next years manifesting mainly in respiratory and joint systems and she was treated by corticosteroids, cyclophosphamid and plasmapheresis. 16. 3. 2007 she underwent kidney transplantation from a deceased donor. Daclizumab, corticosteroids, mycophenolate mofetil a tacrolimus were used as the immunosuppression regime. Postransplant period was uneventful, and patient’s status significantly improved. Aneurysmatic fistula on her arm with negative effect on heart function could be ligated after 3 months. Patient desired pregnancy one year after transplantation, so her immunosuppression treatment was changed (prednisone, tacrolimus, azathioprin) and subsequently she became pregnant. Gravidity was complicated with herpes zoster which required acyclovir treatment and with antibody positivity against toxoplasmosis. Due to signs of gestosis gravidity was terminated in 36. gestation week by Cesarean section (healthy boy 2010 g, 46 cm). Patient developed acute pyelonephritis of transplanted kidney with acute kidney injury, but because of noncompliance she was treated only conservatively. At the present time patient feels well, serum creatinine is approximately 120 μmol/l. Her child suffered from repeated respiratory infections. Successful delivery is a rare event amongst dialysis patients, and even after kidney transplantation it is uncommon. Management of pregnant kidney transplant recipient is complicated and requires a complex care including adjustments in immunosuppression therapy and co-operation between different medical experts.